Why the study?
Does L-dopa reduce blood pressure in young patients with essential hypertension?
Population
36 young patients with essential hypertension
Comparison
L-dopa 250 mg administered orally vs Placebo
Design
RCT, randomized, single-blind
Authors
Loading...
Supports L-dopa for BP lowering in young essential hypertension; extends evidence for dopaminergic BP modulation beyond peripheral DA2 blockade.
Does L-dopa reduce blood pressure in young patients with essential hypertension?
Oral L-dopa significantly lowers blood pressure in young patients with essential hypertension, an effect not blocked by peripheral DA2 receptor blockade.
Saito et al. (1991) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: